Gene Silencing & Epigenetics

Date: Tuesday, 29 April 2014 - Wednesday, 30 April 2014
Location: South San Francisco, CA, USA

Keynote Speakers

George Calin
Professor and The Alan M. Gewirtz Leukemia & Lymphoma Society Scholar, University of Texas MD Anderson Cancer Center

Hakim Djaballah
CEO, Institute Pasteur - Korea

Overview

The conference will focus on gene silencing processes as a way to modulate gene expression, in the hope to find novel ways to help treat human disease. The conference will detail the cutting edge research taking place in the field with a particular emphasis on epigenetics in modulating and controlling development. The latest developments in these two fields will be highlighted and discussed by experts sharing their work.

The conference will be co-located with dPCR & Next-gen Sequencing. Registered delegates will have unrestricted access to all co-located meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.

Agenda Topics

Epigenetics as a Means to Modulate and Control Development
Epigenetics in Cancer
microRNA-based Gene Expression Modulation
RNAi in vivo

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Bhavneet Bhinder, Bioinformatics Engineer, Memorial Sloan Kettering Cancer Center
Aurora Esquela Kerscher, Assistant Professor, Eastern Virginia Medical School
Muller Fabbri, Assistant Professor, University of Southern California
Ajay Goel, Director, Epigenetics and Cancer Prevention, Baylor University Medical Center
Nigel McMillan, Associate Professor, Griffith University
Roya Pedram Fatemi, Staff Scientist, Faghihi Lab, University of Miami
Enal Razvi, Managing Director, Select Biosciences Inc
Aldo Roccaro, Senior Scientist, Dana Farber Cancer Institute
Sheena Saayman, Postdoctoral Fellow, The Scripps Research Institute
Donato Tedesco, Lead Research Scientist, Cellecta Inc